May 27, 2022
The University of Cincinnati's John Breneman, MD, spoke with Imaging Technology News about the completion of enrollment of the FAST-01 trial, the first FLASH proton therapy trial completed in humans.
June 28, 2022
MSN highlighted the University of Cincinnati's Jordan Kharofa and his recent research on how diet and the microbiome affect colorectal cancer risks in young populations.
March 15, 2023
Local television stations including WINK-TV in Fort Myers, Florida and WGEM-TV in Quincy, Illinois highlighted the University of Cincinnati and Cincinnati Children's Hospital Medical Center's first-in-human trial of FLASH radiotherapy.
February 6, 2023
The University of Cincinnati Cancer Center’s Teresa Meier and Sarah Sittenfeld joined 55KRC's Simply Medicine to discuss cervical cancer, including risk factors and the importance of screenings.
March 2, 2023
The University of Cincinnati's Jordan Kharofa provided comments to the Wall Street Journal on a recent study that found a larger share of colorectal cancer patients are being diagnosed at a younger age and at a more dangerous stage of the disease.
April 12, 2022
The University of Cincinnati's Kyle Wang, MD, is the site principal investigator for the Trident trial, studying the effectiveness of earlier electrical treatment through Optune devices to treat glioblastomas.
November 27, 2023
The University of Cincinnati Cancer Center's Andrew Frankart, MD, is leading a new clinical trial that will test the safety and effectiveness of a more targeted radiation dose for patients with large tumors.
September 23, 2022
The University of Cincinnati's Pankaj Desai, PhD, has received a $1.19 million grant from the National Institutes of Health/National Institute of Neurological Disorders and Stroke to continue research into the use of a drug called letrozole to treat glioblastomas, the most deadly form of brain tumors.
May 29, 2024
University of Cincinnati Cancer Center experts will present research on ovarian and blood cancer trials, the link between poor sleep and cancer-related cognitive impairment, and an innovative youth education program at the American Society of Clinical Oncology annual meeting 2024 in Chicago.
May 5, 2023
The University of Cincinnati's Soma Sengupta was a co-first author on research published in Cell Reports Medicine New that found that a cancer stem cell test can accurately decide more effective treatments and lead to increased survival for patients with glioblastoma, a deadly brain tumor.